iDtheinvestordatabase
Home / Directory / Mission BioCapital
Active: new fund Apr 2026 Verified 4 Nov 2026

Mission BioCapital

Cambridge, MA investor providing early-stage capital to life science entrepreneurs, with a shared lab platform and a Platinum Program.

Type
VC firm
Location
United States (Cambridge office)
Stages
Pre-seed
Backs
Biotech and pharma
Sectors
Biotech, Healthtech and life sciences, Medtech
Fund size / AUM
$191.9M Mission Biocapital V (Form D amount sold, 2021)
Latest fund or filing
14 Nov 2025
Portfolio mix
Biotech and pharma 82%; Climate and energy 6%; Consumer apps 3%; Medtech and digital health 3%; Hardware 3%; Consumer products 3% (n=30, 2016 to 2025)

Fund filings (SEC Form D)

Latest fund on file
Mission BioCapital VI
Filed
14 Nov 2025 (amendment)
Fund size
$144M (amount sold)
Fund vehicles filed in the last 12 months
1 (includes feeder and parallel vehicles)

See this fund's filings on SEC EDGAR

Contacts on file

For Mission BioCapital, the paid file holds: 8 named decision-makers with roles; firm contact email (domain checked); LinkedIn page.

Get US Complete, $197 Free sample

One-time payment. No subscription. No account.

Notable investments

Sensorium TherapeuticsAI ProteinsCavalry BiosciencesProgentos TherapeuticsMarch Biosciences

Sources

Last checked 4 Nov 2026. Is something wrong? Tell us.

Appears in 21 lists